Accordingly, further analysis revealed that Nrf2 inhibits the beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) expression by binding to the AREs in the promoter of BACE1 in AD animal models. This evidence concerns the gene BACE1 and Alzheimer disease.